Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial. [electronic resource]
Producer: 20040713Description: 744-9 p. digitalISSN:- 1462-0324
- Adrenal Cortex Hormones -- therapeutic use
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Isoxazoles -- administration & dosage
- Leflunomide
- Male
- Middle Aged
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.